Over 14,700 waiting time modifications completed for Black kidney patients one year after policy implementation
Wednesday, May 8, 2024
New report captures one year of post-implementation data (January 5, 2023 – January 3, 2024).

OPTN Board approves updated variance policy
Wednesday, May 8, 2024
OPOs and transplant hospitals encouraged to recommend protocols for consideration.

Updated median MELD at transplant scores in effect March 27
Friday, April 19, 2024
Scores are updated twice each year.

HRSA and CMS Organ Transplantation Affinity Group (OTAG) webinar recording available
Wednesday, April 17, 2024
OTAG is a federal collaborative aimed at strengthening accountability, equity and performance.

FDA presentation on Regulation of Allograft Heart Valves addresses the role of the OPTN and the FDA in partial heart transplant procedures
Wednesday, April 17, 2024
July 27, 2023 presentation clarifies FDA oversight authority.

FDA presentation on Medical Device Reporting (MDR) Reporting Requirements
Wednesday, April 17, 2024
Feb. 5, 2024 presentation focused on required reporting of adverse events related to malfunctioning or defective medical devices.

OPTN Executive Committee forms two work groups
Monday, April 15, 2024
Groups to make recommendations on OPTN code of conduct, project prioritization.

OPTN Expeditious Task Force town hall set for March 13
Friday, March 8, 2024
OPTN Expeditious Task Force town hall recording available.

New OPTN board members elected for 2024
Friday, March 8, 2024
Terms begin July 1.

White paper analyzes ethical issues in normothermic regional perfusion
Friday, March 8, 2024
Use of consistent and transparent protocols recommended.